BTIG downgrades Sionna Therapeutics stock rating after trial miss — See source for full details.
$SION
Price history, market instrument context, member research, and related headlines in one place.
SION key statistics
NasdaqGMUSD
52-week range
$3.930%$54.97
Latest session $4.02–$4.29Sionna Therapeutics, Inc. (SION) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $4.08, down $0.01 (0.24%) from the previous close of $4.09. It has traded between $4.02 and $4.29 in the latest session. Over the past year it has ranged from $3.93 to $54.97, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 944.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Guggenheim downgrades Sionna Therapeutics stock rating after trial failure — See source for full details.
Raymond James downgrades Sionna Therapeutics stock rating on trial failure — See source for full details.
Sionna Therapeutics GAAP EPS of -$0.66 — See source for full details.
Loading $SION research…